(Q38023121)

27 August 2017

title

ENTPD1/CD39 is a promising therapeutic target in oncology (English)

1 reference

27 August 2017

J Bastid

1

1 reference

27 August 2017

A Cottalorda-Regairaz

2

1 reference

27 August 2017

G Alberici

3

1 reference

27 August 2017

N Bonnefoy

4

1 reference

27 August 2017

J-F Eliaou

5

1 reference

27 August 2017

A Bensussan

6

1 reference

27 August 2017

language of work or name

English

0 references

publication date

2 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

32

1 reference

27 August 2017

issue

14

1 reference

27 August 2017

page(s)

1743-1751

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.269

27 August 2017

exact match

0 references

cites work

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Transient T cell depletion causes regression of melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CTLA-4 blockade: therapeutic potential in cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD39/adenosine pathway is involved in AIDS progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD39/NTPDase-1 activity and expression in normal leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Ecto-enzyme and signaling functions of lymphocyte CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Regulation of macrophage function by adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Adenosine receptors in regulation of dendritic cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

An in vivo model of melanoma: treatment with ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

CD39 and control of cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206) and chemotherapy (temozolomide [TMZ] or dacarbazine [DTIC]) in patients with advanced melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.269

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.269

1 reference

Dimensions Publication ID

27 August 2017

1039552822

0 references

1 reference